Diligence memo · auto-generated · as of July 2, 2026

Regional Diagnostic Laboratories, Inc.

Regional Diagnostic Laboratories, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Regional Diagnostic Laboratories, Inc. operates in Other Health Care, based in BRENTWOOD.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Regional Diagnostic Laboratories, Inc. has raised $9.1M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $4.5M on 2012-04-05.

Most recent recorded round closed around 2012-04-05.

Valuation (modeled)modeled

Provath models Regional Diagnostic Laboratories, Inc. at approximately $92M (range $5.8M–$498M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.79× the median modeled value of Series A Other Health Care companies in 2010–2012 (199 peers) — value vs value, same stage and era. Within the normal band (79% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 14.2 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.0× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 74% of Other Health Care peers (5377 compared).

Modeled value ranks above 77% of those peers.

Closest niche peers: Barrx Medical Inc, Icad Inc, Cas Medical Systems Inc, Cardiosolutions Inc, Ophthonix Inc.

Peoplefiled

7 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.